Gallium Ga 68 dotatate

(NETSPOT®)

NETSPOT®

Drug updated on 1/4/2024

Dosage FormInjection (intravenous; 2.1-5.45 mCi/mL)
Drug ClassRadioactive diagnostic agents
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.

Product Monograph / Prescribing Information

Document TitleYearSource
NETSPOT (gallium Ga 68 dotatate) Prescribing Information.2019Advanced Accelerator Applications USA, Inc., Millburn, NJ

Randomized Controlled Trials


Sex Distribution:

F:40%
M:60%
10Subjects

Year:

2017

Source:Journal of Nuclear Medicine

Clinical Practice Guidelines